132622-65-2

Basic information

• Product Name: (2S,4S)-4-azido-1-[(tert-butoxy)carbonyl]pyrrolidine-2-carboxylic acid
• Synonyms: (2S,4S)-4-azido-1-[(tert-butoxy)carbonyl]pyrrolidine-2-carboxylic acid;(2S,4S)-1-Boc-4-azidopyrrolidine-2-carboxylic acid;Boc-L-Pro(4-N3)-OH*CHA (2S,4S);N-Boc-4-azido-L-proline;1,2-Pyrrolidinedicarboxylic acid, 4-azido-, 1-(1,1-dimethylethyl) ester,(2S,4S)-;(2S,4S)-Boc- 4-azido-pyrrolidine-2-carboxylic acid≥ 99% (HPLC);Boc-cis-Pro(4-azido)-OH;cis-4-Azido-N-(tert-butoxycarbonyl)-L-proline
• CAS NO: 132622-65-2
• Molecular Formula: C₁₀H₁₆N₄O₄
• Molecular Weight: 256.25844
• Mol File: 132622-65-2.mol
• Article Data: 18

Chemical Properties

• Melting Point: 69.0 to 73.0 °C
• Appearance: /
• CAS DataBase Reference: (2S,4S)-4-azido-1-[(tert-butoxy)carbonyl]pyrrolidine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4S)-4-azido-1-[(tert-butoxy)carbonyl]pyrrolidine-2-carboxylic acid(132622-65-2)
• EPA Substance Registry System: (2S,4S)-4-azido-1-[(tert-butoxy)carbonyl]pyrrolidine-2-carboxylic acid(132622-65-2)

Safety Data

• Hazardous Substances Data: 132622-65-2(Hazardous Substances Data)

Usage

Chemical Properties

White crystalline powder

Upstream product

• 132623-03-1 (2S,4S)-4-azido-pyrrolidin-1,2-dicarboxylic acid-1-tert-butyl ester-2-ethyl ester 
• 84520-68-3 N-tert-butoxycarbonyl-cis-4-azido-L-proline methyl ester 
• 74844-91-0 1-tert-butyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 84520-67-2 (2S,4R)-4-(methylsulfonyloxy)pyrrolidine-1,2-dicarboxylic acid 1-tert-butylester-2-methylester 
• 74844-91-0 (2S,4S)-N-tert-butoxycarbonyl-4-hydroxyproline methyl ester 
• 51-35-4 4R-4-hydroxyproline 
• 24424-99-5 di-tert-butyl dicarbonate 
• 121147-93-1 (2S,4S)-2-methyl N-Boc-4-((methylsulfonyl)oxy)pyrrolidine-2-carboxylate 

Downstream Products

• 132622-66-3 cis-1-(1,1-dimethylethyoxycarbonyl)-4-amino-L-proline 
• 892128-58-4 cis-4-azido-L-proline 
• 737765-48-9 (2S,4S)-4-Azido-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-pentafluorophenyl ester 
• 737765-52-5 C₂₆H₂₇F₅N₁₂O₆ 
• 263847-08-1 (2S,4S)-1-(((9H-fluoren-9-yl)methoxy)carbonyl)-4-azidopyrrolidine-2-carboxylic acid 
• 263846-90-8 (2S,4R)-1-((2S,3R)-2-{(S)-5-[((2S,4S)-4-Azido-pyrrolidine-2-carbonyl)-amino]-2-[(4''-pentyloxy-[1,1';4',1'']terphenyl-4-carbonyl)-amino]-pentanoylamino}-3-tert-butoxy-butyryl)-4-tert-butoxy-pyrrolidine-2-carboxylic acid tert-butyl ester 
• 263846-92-0 1-(2-{5-{[1-(2-amino-3-tert-butoxy-butyryl)-4-azido-pyrrolidine-2-carbonyl]-amino}-2-[(4''-pentyloxy-[1,1';4',1'']terphenyl-4-carbonyl)-amino]-pentanoylamino}-3-tert-butoxy-butyryl)-4-tert-butoxy-pyrrolidine-2-carboxylic acid tert-butyl ester 
• 296775-20-7 1-[2-(5-{[1-(2-amino-3-tert-butoxy-butyryl)-4-azido-pyrrolidine-2-carbonyl]-amino}-2-{4-[4-(4-octyloxy-phenyl)-piperazin-1-yl]-benzoylamino}-pentanoylamino)-3-tert-butoxy-butyryl]-pyrrolidine-2-carboxylic acid tert-butyl ester 
• 263846-89-5 C₇₀H₈₈N₈O₁₁ 
• 296774-67-9 C₆₇H₉₀N₁₀O₁₀ 
• 263846-91-9 C₇₈H₁₀₃N₉O₁₃ 
• 296774-68-0 C₇₅H₁₀₅N₁₁O₁₂ 
• 132622-67-4 (4S)-1-(tert-butoxycarbonyl)-4-<<<(p-toluenesulfonyl)imino>aminomethyl>amino>-L-proline 
• 1388224-07-4 C₃₆H₄₂N₁₂O₄ 

Relevant articles and documents

Potent and Selective Conformationally Restricted Neuronal Nitric Oxide Synthase Inhibitors

Selective inhibition of the isoforms of nitric oxide synthase (NOS) in pathologically elevated synthesis of nitric oxide has great therapeutic potential. We previously reported nitroarginine-containing dipeptide amides (Huang, H.; Martasek, P.; Roman, L.

A inhibiting DPP-IV compounds and intermediates

Provided are compounds as presented in formulas IA or IB or pharmaceutically acceptable salts thereof, the preparation method therefor, and uses thereof. Also provided are the intermediates of the compounds and the preparation method therefor. The compounds of the present invention can effectively inhibit DPP-IV activity. Compared to the commercial available medicine, Januvia, compound 1 exhibits strong inhibition against DPP4, but has lower activity inhibition against other DPP family members (DPP2, DPP8, and DPP9). Hence the compound of the present invention can not only effectively inhibit DPP4 from exhibiting medicinal activity, but also lower the activity inhibition against other members of the DPP family, reduce toxic side effect, and have better medicinal safety.

MACROCYCLIC COMPOUNDS FOR INHIBITION OF INHIBITORS OF APOPTOSIS

The invention relates generally to macrocyclic compounds and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of inhibitors of apoptosis (IAPs) and/or are useful in the treatment of medical conditions, such as cancer.